Clinical Trial Update: Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of S-1 plus leucovorin for untreated metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Leucovorin (folinic acid)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED